perillaldehyde has been researched along with Acute Myelogenous Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baeyens, A; Bellau, MLA; Catanzaro, E; Fimognari, C; Guerrini, A; Kerre, T; Krysko, DV; Paganetto, G; Sacchetti, G; Sioen, S; Turrini, E | 1 |
1 other study(ies) available for perillaldehyde and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Perillaldehyde is a new ferroptosis inducer with a relevant clinical potential for acute myeloid leukemia therapy.
Topics: Cell Line, Tumor; Ferroptosis; Humans; Leukemia, Myeloid, Acute; Monoterpenes | 2022 |